In Other News

• Abbott Launches Molecular Test for Novel Coronavirus (COVID-19)

• GenMark Receives FDA Emergency Use Authorization for ePlex SARS-CoV-2 Test

• Diazyme Announces Availability of COVID-19 Antibody Tests

• BD, BioGX Submit EUA Request to FDA for New COVID-19 Diagnostics

• Mesa Receives FDA EUA for 30 Minute POC Molecular COVID-19 Test

• DiaSorin Receives BARDA Funding to Develop Rapid COVID-19 Test

• LexaGene Accelerates FDA EUA Submission of Rapid, Onsite Analyzer for Detection of COVID-19

• Hologic’s Panther Fusion SARS-CoV-2 Assay Receives FDA Emergency Use Authorization

• bioMérieux Receives Emergency Use Authorization for BIOFIRE COVID-19 Test

• Microbiologics Introduces First SARS-CoV-2 RNA IVD CE Marked Control

• Quidel Receives FDA Emergency Use Authorization for Molecular COVID-19 Diagnostic Assay

• Roche Receives Emergency Use FDA Approval for Automated Coronavirus Test

• Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test

• Israeli Researchers Introduce Pooling Method for COVID-19 Testing of Over 60 Patients Simultaneously

• SARS-CoV-2 Detected in Multiple Sample Types

• Promega Custom Manufacturing Capabilities Aid Rapid Development of New Coronavirus Test from Co-Diagnostics

• Coronavirus Screening Test Developed by Johns Hopkins Microbiologists

• Bio-Rad Launches SARS CoV-2 Standard for Coronavirus (COVID-19) Testing

• AMSBIO Launches Recombinant Proteins and Antibodies for Detection of Coronavirus (COVID-19)

• Novel Coronavirus Could Be Targeting Kidneys, Suggests New Data

• Microbiologics Introduces SARS-CoV-2 Synthetic RNA for COVID-19 Research

• Sentinel Diagnostics Develops Ready-To-Use Real-Time PCR Mix for Detection of Novel Coronavirus

• Seegene Launches KFDA-Approved COVID-19 Assay